a developer of gene therapies for fatal and debilitating diseases of the central nervous system
Industry Biotechnology
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MRJAX | 10.91 | -0.02 | -0.18% |
Morgan Stanley Multi-Asset Real Return A | |||
JDSNX | 26.60 | -0.17 | -0.64% |
Janus Henderson Small Cap Value N | |||
GLOSX | 19.83 | -0.13 | -0.65% |
Pioneer Global Sustainable Equity A | |||
SVFKX | 84.59 | -0.71 | -0.83% |
Smead Value R2 | |||
FIFWX | 23.97 | -0.37 | -1.52% |
Fidelity Advisor Founders Z |
A.I.dvisor indicates that over the last year, VYGR has been loosely correlated with PLRX. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if VYGR jumps, then PLRX could also see price increases.
Ticker / NAME | Correlation To VYGR | 1D Price Change % | ||
---|---|---|---|---|
VYGR | 100% | -9.32% | ||
PLRX - VYGR | 44% Loosely correlated | -3.27% | ||
EDIT - VYGR | 43% Loosely correlated | -3.97% | ||
ELVN - VYGR | 41% Loosely correlated | -2.05% | ||
RGNX - VYGR | 40% Loosely correlated | -13.55% | ||
RCKT - VYGR | 40% Loosely correlated | -5.67% | ||
More |